AdvisorShares Vice
ALTAR
Score™
7.2% info Recommen-
dation
OVERWEIGHT
2019E    2020E
P/E
ratio
16.7x P/Sales
ratio
2.1x
P/BV
ratio
2.8x Div.
yield
2.9%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
ACT is an actively managed fund that invests in US companies involved in alcohol-, cannabis-, or tobacco-related activities.

FUND BASICS
Category Global Equities
Fund Sponsor AdvisorShares
Website www.advisorshares.com
Inception date Dec 12, 2017
Assets (mns) $12
Currency USD
Expense ratio 99 bp
Distributions Annually

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian
Weighting Proprietary
Index replication
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 30
Wgt avg mkt cap (mns) $70,996
Large cap (>$10bn) 61.7%
Mid cap ($2-10bn) 12.8%
Small cap (<$2bn) 25.5%
Developed mkts 97.4%
Emerging mkts 2.6%

TOP TEN HOLDINGS
THERMO FISHER SCIENTIFIC INC 6.5 %
ABBOTT LABORATORIES 5.5 %
ABBVIE INC 5.3 %
LVMH MOET HENNESSY-UNSP ADR 5.1 %
NOVARTIS AG-ADR 5.0 %
SCOTTS MIRACLE-GRO CO-CL A 4.8 %
BOSTON BEER COMPANY INC-CL A 4.7 %
BROWN-FORMAN CORP-CLASS B 4.4 %
PHILIP MORRIS INTERNATIONAL 4.2 %
BRITISH AMERICAN TOB-SP ADR 4.2 %
Total 49.7 %

TOP COUNTRY EXPOSURE
UNITED STATES 75.8 %
BRITAIN 8.6 %
FRANCE 6.3 %
SWITZERLAND 5.0 %
BRAZIL 2.4 %
BELGIUM 1.4 %





HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru December 31)
Year-to-date 1 year 5 years 10 years Since Incep.
20.1% 20.1% -- -- -0.2%

Market Correlations
versus... Beta R-squared
S&P500 0.89 68%
MSCI EAFE 0.90 54%
MSCI Emg. Mkts. 0.53 30%

Technical Indicators
Recent close $25.44
30d moving avg. $25.30
Annualized volatility 15.7%
Short interest (ETF) 0.0%
Relative strength (RSI) 60

Liquidity measures
Avg. volume (thou.) 2
Turnover 0.4%
Bid/Ask (% of price) 0.23%
ADV underlying (mns) $3,281

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the AdvisorShares Vice ETF based on the alternatives' overlap in portfolio holdings with ACT. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: ACT Expense: 99 bp ALTAR Score™: 7.2%


ALTERNATIVE ETFs BASED ON OVERLAP WITH ACT
Ticker Fund
Name
Overlap1
vs ACT
(%)
Expense
ratio
(bp)
Savings
vs ACT
(bp)
ALTAR
Score™
(%)
ALTAR
vs ACT
(%)
TOKE Cambria Cannabis 15.6 42 57 -0.2 -7.4
MJ ETFMG Alternative Harvest 13.4 75 24 -3.1 -10.2
JHMS John Hancock Multifactor Consumer Staples 12.8 40 59 7.4 +0.2
RHS Invesco S&P Equal Weight Consumer Staples 12.6 40 59 6.3 -0.8
WBIY WBI Power Factor High Dividend 12.2 70 29 9.8 +2.6
FTXH First Trust Nasdaq Pharmaceuticals 12.0 60 39 4.2 -3.0
IHI iShares DJ US Medical Devices 12.0 43 56 3.6 -3.6
PPH VanEck Vectors Pharmaceuticals 11.7 36 63 8.9 +1.7
ADRU BLDRs Europe 100 ADR 11.6 30 69 7.8 +0.7
FDL First Trust Morningstar Dividend Leaders 11.6 45 54 8.4 +1.2
XLV Health Care Select Sector SPDR 11.1 13 86 6.8 -0.3
ADRD BLDRs Developed Markets 100 ADR 11.0 30 69 8.8 +1.6
IECS iShares Evolved U.S. Consumer Staples 10.9 18 81 5.8 -1.4
VDC Vanguard Consumer Staples 10.8 10 89 5.3 -1.8
FSTA Fidelity MSCI Consumer Staples 10.4 8 91 5.3 -1.8
PEY Invesco High Yield Equity Dividend Acheivers 10.3 53 46 6.3 -0.8
IYH iShares US Healthcare 10.2 43 56 5.9 -1.2
XLP Consumer Staples Select Sector SPDR 10.2 13 86 5.3 -1.9
IEHS iShares Evolved U.S. Healthcare Staples 10.2 18 81 5.6 -1.6
DHS WisdomTree Equity Income 10.0 38 61 7.6 +0.5

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
AdvisorShares Vice
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

OVERWEIGHT

Above average appreciation potential. A rating of OVERWEIGHT is assigned to ETFs with ALTAR Scores in the 4th quintile (ranking higher than 60%-80%) of their category. Typically, funds in this category consist of stocks trading at attractive valuations and/or having above-average fundamentals.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 20.8 %
Divided by: Fwd. P/BV 2.6 x
Less: Expense ratio 99 bp
Equals: ALTAR Score 7.2 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.50 CATEGORY
AVERAGE
1.54
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.